TVALA

Live / Registered — Registered (as of 04 Apr 2023)

What this means for you

Registered since 04 Apr 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Apr 2029: the §8 declaration of use).

Record

Serial number
97106239
Registration number
7020508
Mark type
Word mark
Filed
03 Nov 2021
Published for opposition
20 Sept 2022
Registered
04 Apr 2023
Next maintenance filing
§8 declaration of use, due by 04 Apr 2029 (grace period to 04 Oct 2029)

Goods and services

  • Class 005 — Pharmaceuticals: Drug for human use, namely, pharmaceutical preparation for the treatment of neuroinflammatory disease administered subcutaneously or intravenously to patients with amyotrophic lateral sclerosis

Owner

Prosecution history

  • 04 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 04 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
  • 28 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 25 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 24 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
  • 01 Feb 2023 — USE AMENDMENT FILED
  • 23 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 01 Feb 2023 — TEAS STATEMENT OF USE RECEIVED
  • 15 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 20 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 20 Sept 2022 — PUBLISHED FOR OPPOSITION
  • 31 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 31 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 Aug 2022 — EXAMINER'S AMENDMENT ENTERED

View this trademark record on Rightsy